Item 5.07 Submission of Matters to a Vote of Security Holders
On September 17, 2020, Outlook Therapeutics, Inc. ("the Company") held a Special
Meeting of the Stockholders (the "Special Meeting"). The Special Meeting was
held in a virtual meeting format only, via live webcast on the Internet, with no
physical in-person meeting. At the Special Meeting, the Company's stockholders
voted on a proposal, which is described in more detail in the Company's
definitive proxy statement on Schedule 14A filed with the U.S. Securities and
Exchange Commission on August 18, 2020. There were 127,183,109 shares of Common
Stock outstanding and entitled to vote at the Special Meeting.
Proposal 1.Stockholders approved the amendment and restatement of the Company's
2015 Equity Incentive Plan, as amended, to increase the share reserve and make
certain updating changes. The voting results were as follows:
Votes For Votes Against Abstentions Broker Non-Votes
80,468,028 2,819,696 180,973 0
Item 9.01. Financial Statements and Exhibits
(d) Exhibits.
Exhibit No. Description
99.1 Outlook Therapeutics, Inc. 2015 Equity Incentive Plan, as amended
September 17, 2020.
© Edgar Online, source Glimpses